Literature DB >> 22744245

Progressive multi-focal leukoencephalopathy as a rare lethal complication in untreated sarcoidosis.

Sabine K Hohlfeld1, Huldrych F Günthard, Jonas Zeitz, Pascal Locher, Esther Bachli.   

Abstract

Progressive multi-focal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system caused by reactivation of John Cunningham virus. It is an opportunistic infection affecting patients who are severely immunocompromised due to an underlying disease or secondary to immunosuppressive therapy. To date, no effective antiviral therapy has been established, though several substances are being investigated. The authors present the case of a 39-year-old previously healthy patient who was diagnosed with PML and sarcoidosis stage III without having received prior immunosuppressive treatment. The patient did not respond to treatment with mirtazapine, which has been used empirically, and deceased shortly after diagnosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22744245      PMCID: PMC3387453          DOI: 10.1136/bcr.03.2011.4036

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

Review 1.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

2.  Progressive multifocal leukoencephalopathy as first manifestation of sarcoidosis.

Authors:  Sylvie De Raedt; Patrick Lacor; Alex Michotte; Anja Flamez; Guy Ebinger
Journal:  Clin Neurol Neurosurg       Date:  2007-11-05       Impact factor: 1.876

3.  The human polyomavirus, JCV, uses serotonin receptors to infect cells.

Authors:  Gwendolyn F Elphick; William Querbes; Joslynn A Jordan; Gretchen V Gee; Sylvia Eash; Kate Manley; Aisling Dugan; Megan Stanifer; Anushree Bhatnagar; Wesley K Kroeze; Bryan L Roth; Walter J Atwood
Journal:  Science       Date:  2004-11-19       Impact factor: 47.728

4.  The association of progressive multifocal leukoencephalopathy and sarcoidosis.

Authors:  M A Rosenbloom; D F Uphoff
Journal:  Chest       Date:  1983-03       Impact factor: 9.410

  4 in total
  4 in total

Review 1.  The Diagnosis, Differential Diagnosis, and Treatment of Sarcoidosis.

Authors:  Antje Prasse
Journal:  Dtsch Arztebl Int       Date:  2016-08-22       Impact factor: 5.594

2.  Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine.

Authors:  Rebekka Kurmann; Christian Weisstanner; Piotr Kardas; Hans H Hirsch; Roland Wiest; Bernhard Lämmle; Hansjakob Furrer; Renaud Du Pasquier; Claudio L Bassetti; Mathias Sturzenegger; Heinz Krestel
Journal:  J Neurovirol       Date:  2015-04-28       Impact factor: 2.643

3.  Treating sarcoidosis-associated progressive multifocal leukoencephalopathy with infliximab.

Authors:  Sina C Rosenkranz; Vivien Häußler; Manuela Kolster; Anne Willing; Jakob Matschke; Christoph Röcken; Klarissa Stürner; Frank Leypoldt; Eva Tolosa; Manuel A Friese
Journal:  Brain Commun       Date:  2021-12-16

4.  Posterior fossa progressive multifocal leukoencephalopathy: first presentation of an unknown autoimmune disease.

Authors:  Paulette Scholten; Peter Kralt; Bram Jacobs
Journal:  BMJ Case Rep       Date:  2017-10-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.